$ELTP Recent Headlines Former CEO of Elite Pharm
Post# of 144173
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
Former CEO of Elite Pharmaceuticals sells all shares 9:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:27 p.m. Aug. 8, 2003 - Chris Kraeuter
Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 8:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 8:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 10:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 11:01 p.m. May 9, 2013 - InvestorPlace.com
BlackBerry May Power Ford's Future Generation Cars 4:48 a.m. Today - ACCESSWIRE
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 12:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201 7:01 a.m. Feb. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2014 9:50 a.m. Feb. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Third Quarter Business Update Call on February 18, 2014 3:27 p.m. Feb. 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Analyst Report offers Insight and Market Data by BrokerBank Securities, Inc. 7:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
TrendingWallStreet.com Releases Updates on RFMD, EZPW, GFOX, and ELTP 12:17 a.m. Jan. 30, 2014 - ACCESSWIRE
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product 1:22 p.m. Jan. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 12:50 p.m. Dec. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note 7:00 a.m. Nov. 26, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 4:23 p.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013 7:45 a.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Bridge Loan Facility 6:45 a.m. Oct. 16, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products 6:45 a.m. Oct. 8, 2013 - GlobeNewswire
BlackBerry May be Going Private on Potential Fairfax Deal 8:27 a.m. Sept. 24, 2013 - ACCESSWIRE
Shutterstock Zooms to a new 52-week High after Pricing Secondary Offering 6:29 a.m. Sept. 23, 2013 - ACCESSWIRE
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride 6:51 a.m. Sept. 18, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 8:47 a.m. Sept. 3, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014 3:30 p.m. Aug. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013 11:00 a.m. Aug. 13, 2013 - GlobeNewswire
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)